Intralesional Mode of Drug Administration in Psoriasis

Suja Sathyan, Komal Agarwal, Indrashis Podder, Anant Patil, Leon Kircik, Jeffrey Weinberg, Paul Yamauchi, Stephan Grabbe, Mohamad Goldust

Research output: Contribution to journalArticlepeer-review


The use of various conventional systemic and topical therapies in psoriasis has resulted in various major and minor side effects. Hence, we need to switch to intralesional administration of antipsoriatic drugs, to achieve better safety and efficacy profile. Intralesional drug therapy is most suitable for scalp, nail, and localized and recalcitrant plaque psoriasis. However, there are specific drugs, which can be used for this purpose, under strict monitoring. We have attempted to review all the possible drugs and indications where intralesional administration is feasible, along with their efficacy, adverse effects, dosage, and recommended duration of treatment. J Drugs Dermatol. 2022;21(2):186-190. doi:10.36849/JDD.6196.

Original languageEnglish
Pages (from-to)186-190
Number of pages5
JournalJournal of Drugs in Dermatology
Issue number2
StatePublished - 1 Feb 2022


Dive into the research topics of 'Intralesional Mode of Drug Administration in Psoriasis'. Together they form a unique fingerprint.

Cite this